Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
81
CPRX Quote, Financials, Valuation and Earnings
Last price:
$24.43
Seasonality move
:
6.75%
Day range:
$24.19 - $24.45
52-week range:
$19.05 - $26.58
Dividend yield:
0%
P/E ratio:
14.27x
P/S ratio:
5.37x
P/B ratio:
3.27x
Volume:
513.5K
Avg. volume:
1.3M
1-year change:
13.09%
Market cap:
$3B
Revenue:
$491.7M
EPS (TTM):
$1.71
Earnings Data
Next earnings date for CPRX
Feb 25
2026
Most recent earnings per share
$0.42
Missed by $0.12
(Nov 5/2025)
Consensus Estimate
$0.54
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CPRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $141.5M | -- | -- | $0.46 | -- |
| 11/05/2025 | Q3 | $136.8M | $148.4M | $0.42 | $0.54 | -$0.12 |
| 08/06/2025 | Q2 | $140.4M | $146.6M | $0.41 | $0.54 | -$0.14 |
| 05/07/2025 | Q1 | $131.1M | $141.4M | $0.45 | $0.53 | -$0.08 |
| 02/26/2025 | Q4 | $134.2M | $141.8M | $0.44 | $0.55 | -$0.10 |
| 11/07/2024 | Q3 | $123.4M | $128.7M | $0.35 | $0.51 | -$0.16 |
| 08/07/2024 | Q2 | $111.9M | $122.7M | $0.33 | $0.43 | -$0.10 |
| 05/08/2024 | Q1 | $98.8M | $98.5M | $0.19 | $0.30 | -$0.11 |
| 02/28/2024 | Q4 | $105.9M | $110.6M | $0.31 | $0.46 | -$0.15 |
| 11/08/2023 | Q3 | -- | -- | -$0.29 | $0.45 | -$0.74 |
| 08/09/2023 | Q2 | -- | -- | $0.33 | $0.41 | -$0.08 |
| 05/10/2023 | Q1 | -- | -- | $0.26 | $0.31 | -$0.05 |
| 03/15/2023 | Q4 | -- | -- | $0.22 | $0.20 | $0.02 |
| 11/09/2022 | Q3 | -- | -- | $0.20 | $0.19 | $0.01 |
| 08/09/2022 | Q2 | -- | -- | $0.20 | $0.17 | $0.04 |
| 05/10/2022 | Q1 | -- | -- | $0.12 | $0.14 | -$0.02 |
| 03/16/2022 | Q4 | -- | -- | $0.09 | $0.12 | -$0.03 |
| 11/09/2021 | Q3 | -- | -- | $0.10 | $0.12 | -$0.02 |
| 08/09/2021 | Q2 | -- | -- | $0.11 | $0.10 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | $0.07 | $0.09 | -$0.02 |
| 03/15/2021 | Q4 | -- | -- | $0.11 | $0.07 | $0.04 |
| 11/09/2020 | Q3 | -- | -- | $0.41 | $0.10 | $0.31 |
| 08/10/2020 | Q2 | -- | -- | $0.09 | $0.09 | -$0.00 |
| 05/11/2020 | Q1 | -- | -- | $0.10 | $0.09 | $0.01 |
| 03/16/2020 | Q4 | -- | -- | $0.07 | $0.10 | -$0.03 |
| 11/12/2019 | Q3 | -- | -- | $0.13 | $0.12 | $0.01 |
| 08/07/2019 | Q2 | -- | -- | $0.10 | $0.02 | $0.08 |
| 05/13/2019 | Q1 | -- | -- | -$0.01 | -$0.13 | $0.12 |
| 03/18/2019 | Q4 | -- | -- | -$0.14 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | -$0.08 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/14/2018 | Q4 | -- | -- | -$0.06 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.05 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.05 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/15/2017 | Q4 | -- | -- | -$0.05 | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -$0.05 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -$0.07 | -- | -- |
| 03/16/2016 | Q4 | -- | -- | -$0.07 | -- | -- |
Catalyst Pharmaceuticals, Inc. Earnings Questions
-
How Much did Catalyst Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Catalyst Pharmaceuticals, Inc. reported $148.4M worth of top line sales in its most recent quarter.
-
Did Catalyst Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Catalyst Pharmaceuticals, Inc. announced earnings per share of $0.42 which represents a miss of analyst forecast a $0.54 per share.
-
Is Catalyst Pharmaceuticals, Inc. Profitable?
Catalyst Pharmaceuticals, Inc. reported $116.4M that represents $0.92 per share over the last quarter.
-
What is the Analyst Consensus for Catalyst Pharmaceuticals, Inc. EPS Next Year?
Catalyst Pharmaceuticals, Inc.'s earnings are forecast to grow from $1.31 per share to $2.06 per share next year representing an increase of 90.91%.
-
When is Catalyst Pharmaceuticals, Inc.'s Earnings Date?
Catalyst Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
